# LB Pharmaceuticals Inc: filings

LBRX · Nasdaq · CIK 1691082 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lbrx.md) · [Financials](/companies/lbrx/financials.md) · [Filings](/companies/lbrx/filings.md) · [Insiders](/companies/lbrx/insiders.md)

## Reports and events: 27 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 29, 3 20, 8-K 16, 424B3 9, D 9, SCHEDULE 13G 6, CORRESP 5, SCHEDULE 13G/A 5, UPLOAD 4, 10-Q 3, EFFECT 3, D/A 2, DRS/A 2, DRSLTR 2, S-1 2, S-8 2, SCHEDULE 13D 2, 10-K 1, 144 1, 424B4 1, 8-A12B 1, ARS 1, CERT 1, DEF 14A 1, DEFA14A 1, DRS 1, POS AM 1, S-1/A 1, S-1MEF 1, S-3ASR 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-15 | 12:05 ET | [8-K](/filings/0001193125-26-391358.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-391358 |
| 2026-09-03 | 12:05 ET | [8-K](/filings/0001193125-26-381076.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-381076 |
| 2026-08-11 | 12:10 ET | [10-Q](/filings/0001193125-26-343490.md) | Quarterly report, period 2026-06-30 | 0001193125-26-343490 |
| 2026-08-11 | 12:05 ET | [8-K](/filings/0001193125-26-343479.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343479 |
| 2026-07-29 | 12:05 ET | [8-K](/filings/0001193125-26-322208.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-322208 |
| 2026-07-22 | 12:14 ET | [8-K](/filings/0001193125-26-311357.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-311357 |
| 2026-06-10 | 20:16 ET | [8-K](/filings/0001193125-26-265867.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-265867 |
| 2026-06-09 | 20:05 ET | [8-K](/filings/0001193125-26-263724.md) | 5.07 Shareholder vote results | 0001193125-26-263724 |
| 2026-05-12 | 20:31 ET | [10-Q](/filings/0001193125-26-219607.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219607 |
| 2026-05-12 | 20:21 ET | [8-K](/filings/0001193125-26-219529.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219529 |
| 2026-04-23 | 20:06 ET | [DEF 14A](/filings/0001193125-26-173679.md) | Proxy statement, period 2026-06-03 | 0001193125-26-173679 |
| 2026-04-06 | 20:05 ET | [S-1](/filings/0001193125-26-143724.md) | Registration statement | 0001193125-26-143724 |
| 2026-03-26 | 20:32 ET | [10-K](/filings/0001193125-26-126368.md) | Annual report, period 2025-12-31 | 0001193125-26-126368 |
| 2026-03-26 | 20:07 ET | [8-K](/filings/0001193125-26-126223.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126223 |
| 2026-03-16 | 20:40 ET | [8-K](/filings/0001193125-26-108474.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-108474 |
| 2026-03-10 | 12:15 ET | [8-K](/filings/0001193125-26-099419.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-099419 |
| 2026-02-10 | 21:30 ET | [SCHEDULE 13D/A](/filings/0001193125-26-044781.md) | Ownership report, active investor, amended | 0001193125-26-044781 |
| 2026-02-05 | 13:15 ET | [8-K](/filings/0001193125-26-038539.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-038539 |
| 2025-11-13 | 13:15 ET | [8-K](/filings/0001193125-25-279074.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-279074 |
| 2025-11-12 | 13:17 ET | [8-K](/filings/0001193125-25-276070.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-276070 |
| 2025-11-06 | 13:23 ET | [10-Q](/filings/0001193125-25-268174.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268174 |
| 2025-11-06 | 13:13 ET | [8-K](/filings/0001193125-25-268154.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268154 |
| 2025-09-25 | 14:55 ET | [SCHEDULE 13D](/filings/0001213900-25-091474.md) | Ownership report, active investor | 0001213900-25-091474 |
| 2025-09-19 | 20:30 ET | [SCHEDULE 13D](/filings/0001193125-25-209153.md) | Ownership report, active investor | 0001193125-25-209153 |
| 2025-09-12 | 20:06 ET | [8-K](/filings/0001193125-25-202195.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-202195 |
| 2025-09-08 | 14:03 ET | [S-1/A](/filings/0001193125-25-197877.md) | Registration statement, amended | 0001193125-25-197877 |
| 2025-08-22 | 20:49 ET | [S-1](/filings/0001193125-25-186467.md) | Registration statement | 0001193125-25-186467 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.